ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Europe 2026
  • Program
  • Paper
  • Is Protocolized Stopping Lifelong Therapy With Eculizumab With Disease Monitoring and Retreatment for Eligible Atypical Hemolytic Uremic Syndrome (aHUS) Patients Cost-Effective? An Economic Evaluation of the SETS aHUS Trial

    Sep 9, 2025, 16:22 PM
  • From the Outside Looking in: Patient Advocacy Groups' and Healthcare Providers' Perspectives on Patient Engagement Strategies in the Israeli Health Technology Assessment Process

    Sep 9, 2025, 16:22 PM
  • Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland

    Sep 9, 2025, 16:22 PM
  • Systems Simulation Methods for the Economic Evaluation of Non-Medicines and Nonsurgical Interventions: A Systematic Literature Review of Quality and Methods for Reproducing Complexity in Health and Health Behaviors

    Sep 9, 2025, 16:22 PM
  • Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-Analysis

    Sep 9, 2025, 16:22 PM
  • Integrating Patient Perspectives Into Drug Reimbursement Decisions: Insights From Taiwan’s Deliberative HTA Process

    Sep 9, 2025, 16:22 PM
  • Developing an HER-Based Multifeature Machine Learning Model to Identify Lung Cancer Subtype

    Sep 9, 2025, 16:22 PM
  • Indirect Treatment Comparisons in Economic Evaluations Submitted to the French Health Authority (CEESP) Since 2014

    Sep 9, 2025, 16:22 PM
  • A Method to Estimate Causally Related Cost Savings of a Preventive Intervention: An Analysis Using the Wellness-Star☆ Database

    Sep 9, 2025, 16:22 PM
  • The Effects of Disease Modifying Anti-Rheumatic Drugs (DMARDs) on Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analyses

    Sep 9, 2025, 16:22 PM
  • Screening for Chronic Kidney Disease (CKD): A Systematic Review and Meta-Analysis of Trials

    Sep 9, 2025, 16:22 PM
  • Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States

    Sep 9, 2025, 16:22 PM
  • Antibody-Drug Conjugates in Colorectal Cancer: A Scoping Review of Current Evidence and Emerging Clinical Trends

    Sep 9, 2025, 16:22 PM
  • Is Less More? Aggregating Health States in State Transition Models

    Sep 9, 2025, 16:22 PM
  • What About a Latent Cure Model? Assessing Cure Models’ Performance in Pediatric Acute Lymphoblastic Leukemia Treated With Tisagenlecleucel

    Sep 9, 2025, 16:22 PM
  • Integrating PROMs Into Real-World Ophthalmology Practice: A Pilot Project on Neovascular AMD

    Sep 9, 2025, 16:22 PM
  • Diagnostic Patterns and Subtype Overlap in Idiopathic Inflammatory Myopathies: A Retrospective Claims-Based Cohort Study

    Sep 9, 2025, 16:22 PM
  • Leveraging Generative Artificial Intelligence for the Creation of Global Value Dossiers Through a RAG Pipeline and Multi-Agent Integration

    Sep 9, 2025, 16:22 PM
  • Comorbidities As a Risk Predictor of Kidney Disease Progression Among Patients Diagnosed With Chronic Kidney Disease

    Sep 9, 2025, 16:22 PM
  • BHM and BHM-Based Extrapolations in an HTA Framework

    Sep 9, 2025, 16:22 PM
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group